StockData
Biodesix Inc logo

Biodesix Inc (BDSX) income statement

BDSXNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30
$8.40−0.48 (-5.41%)

Close on Nov 18, 2026Market cap $88.63MP/E –Yield –

Biodesix Inc income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
–
Operating margin
-20.0%
Net margin
-27.0%
Return on equity, FY2025
-383.1%

Financial strength

Current ratio
2.85
Debt to equity
5.12
Debt to assets
49.1%
Cash to current liabilities
196.2%

Valuation

P/E ratio
–
Price to sales
0.86
Price to book
9.69
Dividend yield
–

See a number that looks wrong?